drugset / Trial / NCT06914180
Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia
Not yet recruiting
174 enrolled
Beijing Tiantan Hospital
Beijing Ditan Hospital · collabBeijing Xiaotangshan Hospital · collabHengshui People's Hospital · collabThe First Hospital of Fangshan District,Beijing · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial's primary objective is to compare the analgesic efficacy of esketamine in combination with pulsed radiofrequency (PRF) against that of PRF monotherapy in patients with trigeminal postherpetic neuralgia (TPHN).
Timeline
- Start
- 2025-04-01
- Primary completion
- 2026-04-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 8 mg | Intravenous |
| Comparator | Pregabalin | Small molecule | — | — |